Although there were no changes in the production of cytokine IFN-γ in the plasma of MS patients, when we evaluated the production of this cytokine in the supernatant of PBMCs, there was an increase, particularly in patients with SP. This evidence concerns the gene IFNG and myeloid sarcoma.